Muhayman Sadiq | Radiology | Best Researcher Award

Dr. Muhayman Sadiq | Radiology | Best Researcher Award

UTHealth Houston | United States

Dr. Muhayman Sadiq is an outstanding clinician–scientist specializing in diagnostic and musculoskeletal radiology, currently serving as a Preliminary Internal Medicine Resident at McGovern Medical School, UTHealth Houston, with an advanced specialty in Diagnostic Radiology, in collaboration with the MD Anderson Cancer Center. A Valedictorian and MBBS Gold Medalist from King’s College London, Dr. Sadiq has earned numerous accolades, including the Betuel Prize in Medicine, Cheselden Medal, Todd Prize, EFORT Jacques Duparc Award, and multiple distinctions for academic and research excellence. His scholarly portfolio includes 7 full-length manuscripts, 6 book chapters (Springer, ARRS, Medblend), and 40+ international conference presentations across RSNA, ARRS, ACR, ASER, and ECR. He has achieved 15 citations, 7 indexed documents, and an h-index of 2, reflecting early-career research impact. His areas of research encompass AI in radiology, musculoskeletal imaging, molecular imaging, and surgical sustainability. Beyond research, he contributes as a Junior Editor at ACORE, reviewer for PLOS One and Medblend Publishing, and Founder & President of the National Education and Mentorship Society (UK). Fluent in English, Urdu, and Hindi, Dr. Sadiq demonstrates a rare combination of clinical excellence, academic leadership, and humanitarian engagement, making him a highly deserving candidate for recognition among the next generation of global radiology innovators.

Profile: Scopus | Orcid

Featured Publications

Musbahi, O., Ahmed, A., Hall, T., Kutyla, K., Sadiq, M., Cobb, J., Bottle, A., Van Arkel, R., & Jones, G. (2025). Deep learning classification models demonstrate high accuracy and clinical potential in radiograph interpretation in the arthroplasty clinical pathway: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.

Ng, J., Sadiq, M., & Mansoor, Q. (2023). Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder. Journal of Oncology Pharmacy Practice.